BeStock  
股票 › 医疗器械 › HAE

海默内提克斯 HAE

美股市值排名 #2005医疗器械
$119.93 −$4.18 (-3.37%)
休市 · Nov 6, 9:50 pm ET · 最新盘后价 $119.93 0.00%
开盘$121.16
昨收$124.11
当日区间$116.79 – $123.75
成交量834.7K
市值$5.46B
市盈率(TTM)53.1
股息率–

基本面

最新报告季度:Q1, ended Jun 2026

营收$339.38M+5.6% YoY
营业利润$57.46M+6.7% YoY
净利润$33.01M-3.0% YoY
摊薄每股收益$0.72+2.9% YoY
自由现金流$44.42M+225.6% YoY
经营现金流$52.32M

营收,近8个季度

$345.5MSep '24$348.5MDec '24$330.6MMar '25$321.4MJun '25$327.3MSep '25$339.0MDec '25$346.4MMar '26$339.4MJun '26

净利润,近8个季度

$33.8MSep '24$37.5MDec '24$58.0MMar '25$34.0MJun '25$38.7MSep '25$44.7MDec '25$-20.1MMar '26$33.0MJun '26

各季度摊薄每股收益

0.66Sep '240.74Dec '241.17Mar '250.70Jun '250.81Sep '250.95Dec '25-0.44Mar '260.72Jun '26

各季度自由现金流

$39.4MSep '24$35.2MDec '24$100.9MMar '25$13.6MJun '25$106.3MSep '25$87.2MDec '25$53.3MMar '26$44.4MJun '26

年度营收

$870.5MFY21$993.2MFY22$1.2BFY23$1.3BFY24$1.4BFY25$1.3BFY26

盈利能力与资产负债表

毛利率59.0%
营业利润率18.1%
净利率7.1%
净资产收益率11.2%
资产收益率4.0%
投入资本回报率5.7%
流动比率3.08
负债/资产比率64.6%
现金及投资$223.38M
总负债$1.17B
净现金(净负债)-$950.77M
自由现金流/营收21.5%

营收构成

2027/Q1 季度

按业务线

  • Apheresis$191.32M 56.4%
  • MedSurg$148.06M 43.6%

利润表

项目 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
报告营业总收入 $339.38M $1.33B $346.35M $338.97M $327.32M
营业总收入 $339.38M $1.33B $346.35M $338.97M $327.32M
营业成本 $136.58M $546.44M $148.14M $136.58M $132.57M
毛利润 $202.80M $787.59M $198.21M $202.39M $194.74M
营业费用 $145.35M $546.19M $145.87M $134.27M $127.67M
销售及管理费用 $118.94M $442.42M $120.93M $109.15M $101.62M
研发费用 $16.20M $59.77M $14.45M $14.19M $14.87M
折旧、摊销与折耗 $10.20M $44.00M $10.49M $10.93M $11.18M
-折旧与摊销 $10.20M $44.00M $10.49M $10.93M $11.18M
营业利润 $57.46M $241.40M $52.34M $68.11M $67.08M
非经营性利息净收入(支出) -$9.88M -$28.70M -$5.37M -$7.42M -$7.21M
非经营性利息支出 $9.88M $28.70M $5.37M $7.42M $7.21M
税前利润 $47.57M $128.03M -$28.40M $59.98M $51.29M
税费 $14.56M $30.72M -$8.25M $15.24M $12.60M
净利润 $33.01M $97.31M -$20.15M $44.74M $38.68M
持续经营利润 $33.01M $97.31M -$20.15M $44.74M $38.68M
归属母公司净利润 $33.01M $97.31M -$20.15M $44.74M $38.68M
归属普通股股东净利润 $33.01M $97.31M -$20.15M $44.74M $38.68M
基本每股收益 $0.73 $2.06 -$0.44 $0.96 $0.81
摊薄每股收益 $0.72 $2.05 -$0.44 $0.95 $0.81
其他收入(支出) – -$84.67M -$75.37M -$716,000.00 -$8.58M
特殊收益(费用) – -$84.67M -$75.37M -$716,000.00 -$8.58M
-减:重组及并购费用 – -$1.88M – – –
-减:资本性资产减值 – $86.55M $77.25M $716,000.00 $8.58M

资产负债表

项目 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
总资产 $2.37B $2.40B $2.40B $2.49B $2.44B
流动资产合计 $810.83M $834.88M $834.88M $943.67M $899.68M
现金及现金等价物与短期投资 $223.38M $245.44M $245.44M $363.37M $296.43M
-现金及现金等价物 $223.38M $245.44M $245.44M $363.37M $296.43M
应收款 $216.07M $216.86M $216.86M $195.71M $207.07M
-应收账款 $216.07M $216.86M $216.86M $195.71M $207.07M
存货 $306.74M $306.37M $306.37M $321.19M $336.21M
其他流动资产 $64.64M $66.21M $66.21M $63.42M $59.98M
非流动资产合计 $1.55B $1.56B $1.56B $1.55B $1.54B
固定资产净值 $303.78M $305.76M $305.76M $297.23M $292.48M
-固定资产原值 $854.27M $841.83M $841.83M $836.81M $815.31M
-累计折旧 -$550.49M -$536.07M -$536.07M -$539.58M -$522.83M
商誉及其他无形资产 $1.09B $1.10B $1.10B $1.03B $1.03B
-商誉 $656.88M $656.37M $656.37M $606.83M $606.10M
-其他无形资产 $434.51M $447.66M $447.66M $419.73M $428.36M
一年以上递延资产 $9.43M $9.52M $9.52M $7.33M $7.57M
其他非流动资产 $149.96M $141.74M $141.74M $216.09M $207.97M
负债合计 $1.53B $1.60B $1.60B $1.58B $1.59B
流动负债合计 $263.24M $282.60M $282.60M $539.87M $548.32M
应付款 $56.34M $51.06M $51.06M $48.69M $61.69M
-应付账款 $56.34M $51.06M $51.06M $48.69M $61.69M
一年内应计费用 $38.15M $68.19M $68.19M $52.10M $48.27M
短期债务及融资租赁负债 $4.96M $5.02M $5.02M $304.75M $304.34M
-一年内到期债务 $4.96M $5.02M $5.02M $304.75M $304.34M
其他流动负债 $163.80M $116.03M $116.03M $134.33M $134.02M
非流动负债合计 $1.27B $1.32B $1.32B $1.04B $1.04B
长期债务及融资租赁负债 $1.17B $1.22B $1.22B $919.99M $920.39M
-长期债务 $1.17B $1.22B $1.22B $919.99M $920.39M
一年以上递延负债 $38.69M $38.05M $38.05M $55.98M $58.20M
其他非流动负债 $57.17M $59.39M $59.39M $63.61M $66.07M
股东权益合计 $837.10M $796.32M $796.32M $911.45M $849.17M
股东权益 $837.10M $796.32M $796.32M $911.45M $849.17M
股本 $455,000.00 $453,000.00 $453,000.00 $468,000.00 $467,000.00
-普通股 $455,000.00 $453,000.00 $453,000.00 $468,000.00 $467,000.00
资本公积 $566.76M $554.14M $554.14M $564.50M $552.91M
留存收益 $311.52M $279.34M $279.34M $381.09M $336.32M
不影响留存收益的损益 -$41.63M -$37.61M -$37.61M -$34.61M -$40.53M
一年内递延负债 – $42.31M $42.31M – –

现金流量表

项目 2027 Q1 2026 ANNUAL 2026 Q4 2026 Q3 2026 Q2
经营活动现金流 $52.32M $293.22M $70.94M $93.56M $111.32M
持续经营经营活动现金流净额 $52.32M $293.22M $70.94M $93.56M $111.32M
持续经营净利润 $33.01M $97.31M -$20.15M $44.74M $38.68M
折旧、折耗与摊销 $27.11M $111.72M $27.32M $27.39M $28.26M
递延税款 $668,000.00 -$714,000.00 $5.30M -$2.06M -$725,000.00
其他非现金项目 $2.23M $3.94M -$6.63M $3.40M $3.16M
营运资金变动 -$20.00M -$12.93M $4.66M $11.81M $26.09M
-应收款变动 $297,000.00 -$14.88M -$22.24M $11.06M -$7.26M
-存货变动 -$1.00M $47.36M $8.46M $13.84M $21.76M
-预付资产变动 $6.10M -$4.53M -$5.89M -$1.78M -$210,000.00
-应付账款及应计费用变动 -$12.62M -$16.57M $20.32M -$6.70M $17.70M
-其他营运资金变动 -$12.78M -$24.30M $4.00M -$4.61M -$5.90M
投资活动现金流净额 -$22.23M -$179.55M -$86.61M -$29.47M -$30.47M
持续经营投资活动现金流净额 -$22.23M -$179.55M -$86.61M -$29.47M -$30.47M
资本支出 -$7.91M -$32.78M -$17.66M -$6.35M -$5.02M
固定资产购置及出售净额 $237,000.00 $1.38M $526,000.00 $432,000.00 $120,000.00
投资购置及出售净额 -$9.00M -$36.07M – – –
其他投资变动净额 -$5.57M -$51.89M $26.77M -$23.55M -$43.66M
筹资活动现金流 -$51.53M -$178.46M -$101.50M $2.03M -$76.55M
持续经营筹资活动现金流净额 -$51.53M -$178.46M -$101.50M $2.03M -$76.55M
债务发行及偿还净额 -$51.56M -$6.25M -$1.56M -$1.56M -$1.56M
股票期权行使所得 $49,000.00 $2.89M $76,000.00 $3.61M $49,000.00
其他筹资费用净额 -$14,000.00 -$102,000.00 -$13,000.00 -$14,000.00 -$39,000.00
期末现金余额 $223.38M $245.44M $245.44M $363.37M $296.43M
现金净变动 -$21.44M -$64.79M -$117.17M $66.13M $4.30M
期初现金余额 $245.44M $306.76M $363.37M $296.43M $292.90M
汇率变动影响 -$617,000.00 $3.46M -$756,000.00 $810,000.00 -$773,000.00
自由现金流 $44.42M $260.44M $53.28M $87.22M $106.31M
持续经营损益 – -$26.47M -$25.94M -$218,000.00 –
业务购买及出售净额 – -$60.18M -$60.18M $0.00 –
普通股发行净额 – -$175.00M -$100.00M $0.00 –

讨论区

暂无评论——快来第一个聊聊 HAE。

登录后参与讨论。

Scroll to Top